Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1Motor Activity 1Hodgkin Disease 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1Disease 1

Interventions

Fluorouracil 9Oxaliplatin 7Nivolumab 6Leucovorin 6Capecitabine 6fludarabine 4Paclitaxel 4Docetaxel 4Cyclophosphamide 4zimberelimab 3pembrolizumab 3aldesleukin 3Trastuzumab 3Ramucirumab 3ulixertinib 2trastuzumab deruxtecan 2fludarabine phosphate 2Specimen Handling 2Irinotecan 2Folfox protocol 2Cisplatin 2zolbetuximab 1zanidatamab 1trifluridine tipiracil drug combination 1trastuzumab biosimilar HLX02 1trametinib 1toripalimab 1tislelizumab 1sodium propionate 1sapanisertib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Stomach Neoplasms × High-Intensity Interval Training × 30 days × Clear all
NCT07561840 2026-05-19

Exercise Training After Upper Gastrointestinal Cancer Surgery

Kansai Medical University

Phase NA Recruiting
171 enrolled
Gastrointestinal

Disease, Esophageal Neoplasms, Gastrointestinal Neoplasms, Motor Activity, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡